|
| Exchange Disseminated Time 27/07/2016 16:26:16 | Sun Pharmaceutical Industries Ltd has informed BSE that the Company on July 27, 2016 signed an agreement with RPG Life Sciences Ltd to divest seven prescription brands in India, owned by Sun Pharmaceutical Industries Limited and its subsidiary, for a consideration of INR 41 Crores.
The 7 (seven) divested brands include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment.
This divestment is subject to receipt of Competition Commission of India’s (CCI) approval. |
|
|